Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -15.82%228.93K | -37.56%186.16K | 296.42%923.79K | -39.65%1.39M | -58.80%589.87K | 8.11%271.96K | 29.08%298.13K | -40.83%233.03K | 91.14%2.31M | 325.37%1.43M |
| Selling and administrative expenses | -62.64%63.17K | -22.54%79.64K | 22.78%111.9K | -14.53%585.96K | 41.15%222.91K | 8.19%169.09K | 17.53%102.82K | -67.90%91.14K | -2.40%685.58K | -12.62%157.93K |
| -General and administrative expense | -62.64%63.17K | -22.54%79.64K | 22.78%111.9K | -14.53%585.96K | 41.15%222.91K | 8.19%169.09K | 17.53%102.82K | -67.90%91.14K | -2.40%685.58K | -12.62%157.93K |
| Other operating expenses | 61.13%165.75K | -45.46%106.52K | 472.19%811.89K | -50.26%807.04K | -71.19%366.96K | 7.99%102.87K | 36.12%195.32K | 29.01%141.89K | 221.20%1.62M | 717.28%1.27M |
| Operating profit | 15.82%-228.93K | 37.56%-186.16K | -296.42%-923.79K | 39.65%-1.39M | 58.80%-589.87K | -8.11%-271.96K | -29.08%-298.13K | 40.83%-233.03K | -91.14%-2.31M | -325.37%-1.43M |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | 652.49%5.43K | -240.59%-6.77K | -93.43%824 | -41.03%129.85K | -13.32%111.76K | -98.41%722 | -51.78%4.82K | -65.01%12.55K | 7.37%220.19K | -17.82%128.94K |
| Gain on sale of security | 372.19%5.43K | 38.61%-6.77K | -84.92%824 | -73.06%-16.08K | -302.79%-8.51K | -12.77%-2K | -471.31%-11.03K | 257.21%5.46K | 3.25%-9.29K | 3.74%-2.11K |
| Other non-operating income (expenses) | ---- | ---- | ---- | -36.41%145.92K | -8.23%120.27K | -94.24%2.72K | 32.96%15.85K | -81.99%7.09K | 6.89%229.48K | -17.62%131.05K |
| Income before tax | 17.60%-223.49K | 34.22%-192.93K | -318.61%-922.97K | 39.50%-1.26M | 63.30%-478.11K | -31.57%-271.24K | -32.73%-293.32K | 38.41%-220.48K | -108.28%-2.09M | -625.00%-1.3M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 17.60%-223.49K | 34.22%-192.93K | -318.61%-922.97K | 39.50%-1.26M | 63.30%-478.11K | -31.57%-271.24K | -32.73%-293.32K | 38.41%-220.48K | -108.28%-2.09M | -625.00%-1.3M |
| Net income continuous operations | 17.60%-223.49K | 34.22%-192.93K | -318.61%-922.97K | 39.50%-1.26M | 63.30%-478.11K | -31.57%-271.24K | -32.73%-293.32K | 38.41%-220.48K | -108.28%-2.09M | -625.00%-1.3M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 17.60%-223.49K | 34.22%-192.93K | -318.61%-922.97K | 39.50%-1.26M | 63.30%-478.11K | -31.57%-271.24K | -32.73%-293.32K | 38.41%-220.48K | -108.28%-2.09M | -625.00%-1.3M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 17.60%-223.49K | 34.22%-192.93K | -318.61%-922.97K | 39.50%-1.26M | 63.30%-478.11K | -31.57%-271.24K | -32.73%-293.32K | 38.41%-220.48K | -108.28%-2.09M | -625.00%-1.3M |
| Diluted earnings per share | 0 | 0 | -0.01 | 0.00%-0.01 | -91.39%-0.01 | 0 | 0 | 0 | 0.00%-0.01 | -36.39%-0.0052 |
| Basic earnings per share | 0 | 0 | -0.01 | 0.00%-0.01 | -91.39%-0.01 | 0 | 0 | 0 | 0.00%-0.01 | -36.39%-0.0052 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.